Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 2.   Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray
  2. Oyelaran, O.; McShane, L. M.; Dodd, L.; Gildersleeve, J. C.
  3. Journal of Proteome Research. 2009 8(9): 4301-4310.
  1. 3.   Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft
  2. Zhang, H. R.; Chen, F. L.; Xu, C. P.; Ping, Y. F.; Wang, Q. L.; Liang, Z. Q.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2009 93(2): 165-174.
  1. 4.   TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer
  2. Cretney, E.; Shanker, A.; Yagita, H.; Smyth, M. J.; Sayers, T. J.
  3. Immunology and Cell Biology. 2006, FEB; 84(1): 87-98.
  1. 5.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 6.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
  1. 7.   Analysis of mass spectral serum profiles for biomarker selection
  2. Ressom, H. W.; Varghese, R. S.; bdel-Hamid, M.; Eissa, S. A. L.; Saha, D.; Goldman, L.; Petricoin, E. F.; Conrads, T. P.; Veenstra, T. D.; Loffredo, C. A.; Goldman, R.
  3. Bioinformatics. 2005, NOV 1; 21(21): 4039-4045.
  1. 8.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 9.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 10.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Lagarkova, M. A.; Meshcheryakov, A. A.; Lichinitser, M. R.; Karbach, J.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunology Letters. 2005, AUG 15; 100(1): 88-93.
  1. 11.   Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
  2. Carlos, C. A.; Dong, H. F.; Howard, O. M. Z.; Oppenheim, J. J.; Hanisch, F. G.; Finn, O. J.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1628-1635.
  1. 12.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 13.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 14.   Fixation and cryopreservation of whole blood and isolated mononuclear cells: Influence of different procedures on lymphocyte subset analysis by flow cytometry
  2. Pinto, L. A.; Trivett, M. T.; Wallace, D.; Higgins, J.; Baseler, M.; Terabe, M.; Belyakov, I. M.; Berzofsky, J. A.; Hildesheim, A.
  3. Cytometry Part B-Clinical Cytometry. 2005, JAN; 63B(1): 47-55.
  1. 15.   Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice
  2. Kim, H. W.; Park, I. K.; Cho, C. S.; Lee, K. H.; Beck, G. R.; Colburn, N. H.; Cho, M. H.
  3. Cancer Research. 2004, NOV 1; 64(21): 7971-7976.
  1. 16.   Schedule-dependent inhibition of hypoxia-inducible factor-1 alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
  2. Rapisarda, A.; Zalek, J.; Hollingshead, M.; Braunschweig, T.; Uranchimeg, B.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Hewitt, S. M.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004, OCT 1; 64(19): 6845-6848.
  1. 17.   Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis
  2. Yang, H. Y.; Rouse, J.; Lukes, L.; Lancaster, M.; Veenstra, T.; Zhou, M.; Shi, Y.; Park, Y. G.; Hunter, K.
  3. Clinical & Experimental Metastasis. 2004 21(8): 719-735.
  1. 18.   Clinical pharmacology of flavopiridol following a 72-hour continuous infusion
  2. Rudek, M. A.; Bauer, K. S.; Lush, R. M.; Stinson, S. F.; Senderowicz, A. M.; Headlee, D. J.; Arbuck, S. G.; Cox, M. C.; Murgo, A. J.; Sausville, E. A.; Figg, W. D.
  3. Annals of Pharmacotherapy. 2003 37(10): 1369-1374.
  1. 19.   Ukrain (TM) a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines
  2. Panzer, A.; Hamel, E.; Joubert, A. M.; Bianchi, P. C.; Seegers, J. C.
  3. Cancer Letters. 2000 160(2): 149-157.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel